Introduction
avoided by blocking with 3% skim milk (150µl/well) for 2 hours at room temperature.
126
Monkey plasma samples were pre-incubated with 2% FCS to absorb antibodies to FCS 127 components, since they were exposed to FCS by injection of the vaccines or viruses 128 diluted in DMEM containing FCS. After washing three times with PBST, 50µl of 129 appropriately diluted serum/plasma samples or the GP-specific MAb in PBST 130 containing 1% skim milk was added and incubated for 1 hour at room temperature.
131
After washing three times with PBST, the bound antibodies were detected using the by adding 1N sulfuric acid and the optical density (OD) at 450 nm was measured.
139
Phylogenetic analysis. Phylogenetic analysis was based on whole amino acid 140 sequences of filovirus GPs. The sequences were analyzed using GENETYX (Genetyx 
Results

151
Expression and purification of recombinant EBOV and MARV GPs.
152
Expression and secretion of His-EBOV-GP and His-MARV-GP in the supernatants of
153
293T cells transfected with a plasmid encoding His-GP was confirmed by 154 immunoblotting using anti-GP and anti-His MAbs (data not shown).
These 155 recombinant GPs were purified as described in Materials and Methods. All purified
156
His-GPs were detected by SDS-PAGE and immunoblotting, using anti-GP and anti-His
157
MAbs as prominent protein bands of the predicted size of the transmembrane 158 anchor-minus EBOV and MARV GPs (Fig. 2 ). These purified GPs were used as 159 antigens for the ELISA described in the following experiments.
160
Sensitivity of the GP-based ELISA. The sensitivity of the purified GP-based
161
ELISA was tested using anti-EBOV-GP MAb ZGP42/3.7 and anti-MARV-GP MAb 162 AGP127-8. Serial 10-fold dilutions of the antibodies (10 -5 to 10 2 µg/ml) were 163 prepared and the reactivity to each GP antigen was examined (Fig. 3) . The negative
164
control MAb, S139/1, did not bind to any His-GPs in the ELISA. At concentrations 165 ranging from 0.1µg/ml to 100µg/ml, ZGP42/3.7 reacted with all His-EBOV-GPs but not
166
His-MARV-GP, whereas AGP127-8 reacted specifically with His-MARV-GP but not 167 any of the His-EBOV-GP. The detection limit for specific antibodies using this assay 168 was approximately 0.01-0.1µg/ml.
169
Specificity of the GP-based ELISA. Next, the species-specificity of the ELISA
170
was assessed by testing the antisera of mice immunized with VLP containing the 171 respective EBOV and MARV GPs. We found that species-specific IgG antibodies 172 were clearly detected in these mouse antisera (Fig. 4) . All the anti-EBOV IgG
173
antibodies in the sera showed low reactivity to heterologous EBOV GPs, and no (1,000 replicates). Fig 1 Phylogenetic analysis of filovirus GP amino acid sequences The phylogenetic tree was constructed using the neighbor joining Fig. 1 . Phylogenetic analysis of filovirus GP amino acid sequences. The phylogenetic tree was constructed using the neighbor-joining method. For construction of this tree, we used 10 GP amino acid sequences, each comprising a whole GP amino acid sequence. Numbers at branch points indicate bootstrap values (1,000 replicates). were prepared and tested. S139/1 (specific to influenza virus hemagglutinin) was used as a negative control antibody (c). . IgG antibodies detected in experimentally infected monkey sera. C105, C332, C508, and C725 were infected with ZEBOV, whereas C0287 and C0436 were infected with SEBOV. All sera were diluted 1:1,000. Naïve monkey serum was used as a negative control.
Fig. 6.
IgG and IgM antibodies detected in human sera. OD values for specific IgG (a) and IgM (b) antibodies in the patient sera are shown. Sera from 21 individuals were analyzed in 1:1,000 dilutions. Naïve human serum (no. 22) was used as a negative control.
